g-8k_20200511.htm
false 0001398659 0001398659 2020-05-11 2020-05-11

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): May 11, 2020

 

GENPACT LIMITED

(Exact name of registrant as specified in its charter)

 

 

Bermuda

001-33626

98-0533350

(State or other jurisdiction

of incorporation)

(Commission

File Number)

(I.R.S. Employer

Identification No.)

Victoria Place, 5th Floor, 31 Victoria Street

Hamilton HM 10, Bermuda

(Address of Principal Executive Offices) (Zip Code)

Registrant's telephone number, including area code: (441) 294-8000

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

Trading Symbol

Name of each exchange on which registered

Common shares, par value $0.01 per share

G

New York Stock Exchange

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 


 

Item 2.02

Results of Operations and Financial Condition.

On May 11, 2020, Genpact Limited (the “Company”) issued a press release announcing its financial results for the three months ended March 31, 2020.  The Company is furnishing this Form 8-K pursuant to Item 2.02, “Results of Operations and Financial Condition.” A copy of the press release, attached hereto as Exhibit 99.1, is incorporated herein by reference.

The information in this report (including Exhibit 99.1) is being furnished pursuant to Item 2.02 and shall not be deemed to be filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

The Company is making reference to non-GAAP financial information in the press release and on the conference call.  A reconciliation of the non-GAAP financial measures to the most directly comparable GAAP financial measures is contained in the attached press release.

Item 9.01.

Financial Statements and Exhibits.

(d) Exhibits:

 

Exhibit 99.1

  

Press release dated May 11, 2020

Exhibit 104

 

Cover Page Interactive Data File (embedded within the Inline XBRL document)

 


 

Signature

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

GENPACT LIMITED

 

 

 

 

 

Date: May 11, 2020

 

By:

 

/s/ Heather D. White

 

 

Name:

 

Heather D. White

 

 

Title:

 

Senior Vice President, General Counsel and Secretary

 

 

g-ex991_6.htm

Exhibit 99.1

Genpact Reports First Quarter 2020 Results

Revenues of $923 million, Up 14% (14% on a constant currency basis)1

Global Client Revenues of $802 million, Up 14% (15% on a constant currency basis)1

Diluted EPS of $0.44, Up 42%; Adjusted Diluted EPS2 of $0.53, Up 23%

NEW YORK, May 11, 2020 — Genpact Limited (NYSE: G), a global professional services firm focused on delivering digital transformation, today announced financial results for the first quarter ended March 31, 2020.

 

“I am extremely proud of the passion and dedication of the Genpact team around the globe, who have worked tirelessly to support our clients, deliver phenomenal service, and help communities and each other in these unprecedented times. The COVID-19 crisis has disrupted personal lives, businesses, and economies across the world in a very short period of time,” said Tiger” Tyagarajan, Genpact’s president and CEO. “The last couple of months have reinforced the importance of providing flawless execution and ensuring operational stability for our clients. Our focus on Transformation Services has enabled us to bring new solutions to market that are very relevant in the current environment. We have a resilient business model supported by the non-discretionary nature of many of the business-critical services we provide, our diversified global delivery footprint, and limited exposure to some of the industries hardest hit by COVID-19. In a world where digital transformation will take center stage, I am confident we will emerge from this crisis as a stronger company and better partner for our clients.”

Key Financial Results – First Quarter 2020

Total revenue was $923 million, up 14% year-over-year both on an as reported and constant currency basis.1

Revenue from Global Clients was $802 million, up 14% year-over-year (15% on a constant currency basis),1 representing 87% of total revenue.

Revenue from GE was $122 million, up 12% year-over-year, representing 13% of total revenue.

Net income attributable to Genpact Limited shareholders was $86 million, up 41% year-over-year, with a corresponding margin of 9.3%.  

Income from operations was $111 million, up 23% year-over-year, with a corresponding margin of 12.0%.   Adjusted income from operations was $136 million, up 12% year-over-year, with a corresponding margin of 14.7%.3

Diluted earnings per share was $0.44, up 42% year-over-year, and adjusted diluted earnings per share2 was $0.53, up 23% year-over-year.  

Cash utilized in operations was $19 million, compared to $5 million in the first quarter of 2019.

 

1 

Revenue growth on a constant currency basis is a non-GAAP measure and is calculated by restating current-period activity using the prior fiscal period’s foreign currency exchange rates adjusted for hedging gains/losses in such period.

2 

Adjusted diluted earnings per share is a non-GAAP measure. A reconciliation of GAAP diluted earnings per share to adjusted diluted earnings per share is attached to this release.

3 

Adjusted income from operations and adjusted income from operations margin are non-GAAP measures. Reconciliations of each of GAAP income from operations and GAAP net income attributable to Genpact Limited shareholders to adjusted income from operations and GAAP income from operations margin and GAAP net income attributable to Genpact Limited shareholders margin to adjusted income from operations margin are attached to this release.

 

 


 

2020 Outlook

Due to the impact of COVID-19, the company is currently anticipating second quarter revenue to be down 4% to 6% year-over-year, or down 3% to 5% on a constant currency basis.1

 

Due to the uncertainty caused by COVID-19, the company has decided to withdraw its 2020 financial outlook issued on February 6, 2020 until visibility improves.

Conference Call to Discuss Financial Results

Genpact’s management will host an hour-long conference call beginning at 4:30 p.m. ET on May 11, 2020 to discuss the company’s performance for the first quarter ended March 31, 2020. To participate, callers can dial +1 (877) 654-0173 from within the U.S. or +1 (281) 973-6289 from any other country. Callers will be prompted to enter the conference ID, 6282351.

 

A live webcast of the call will also be made available on the Genpact Investor Relations website at https://www.genpact.com/investors. For those who cannot join the call live, a replay will be archived on the Genpact website after the end of the call. A transcript of the call will also be made available on the website.

 


 

About Genpact

Genpact (NYSE: G) is a global professional services firm that makes business transformation real. We drive digital-led innovation and digitally-enabled intelligent operations for our clients, guided by our experience running thousands of processes primarily for Global Fortune 500 companies. We think with design, dream in digital, and solve problems with data and analytics.  Combining our expertise in end-to-end operations and our AI-based platform, Genpact Cora, we focus on the details – all 90,000+ of us. From New York to New Delhi and more than 30 countries in between, we connect every dot, reimagine every process, and reinvent companies’ ways of working. We know that reimagining each step from start to finish creates better business outcomes. Whatever it is, we’ll be there with you – accelerating digital transformation to create bold, lasting results – because transformation happens here.

Safe Harbor

This press release contains certain statements concerning our future growth prospects and financial results and other forward-looking statements, as defined in the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. These statements involve a number of risks, uncertainties and other factors that could cause actual results to differ materially from those in such forward-looking statements. These risks, uncertainties, and other factors include but are not limited to the impact of the COVID-19 pandemic on our business, the health and safety of our employees, clients and our partners and suppliers, as well as the physical and economic impacts of the various recommendations, orders and protocols issued by local and national governmental agencies in light of the evolving situation; a slowdown in the economies and sectors in which our clients operate, a slowdown in the business process outsourcing or information technology services sectors, our ability to develop and successfully execute our business strategies, the risks and uncertainties arising from our past and future acquisitions, our ability to convert bookings to revenues, our ability to manage growth, factors which may impact our cost advantage, wage increases, changes in tax rates and tax legislation and other laws and regulations, our ability to attract and retain skilled professionals, risks and uncertainties regarding fluctuations in our earnings, foreign currency fluctuations, general economic conditions affecting our industry, political, economic or business conditions in countries in which we operate, including the uncertainty relating to the withdrawal of the United Kingdom from the European Union, commonly known as Brexit, as well as other risks detailed in our reports filed with the U.S. Securities and Exchange Commission, including Genpact's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. These filings are available at www.sec.gov. Genpact may from time to time make additional written and oral forward-looking statements, including statements contained in our filings with the Securities and Exchange Commission and our reports to shareholders. Although Genpact believes that these forward-looking statements are based on reasonable assumptions, you are cautioned not to put undue reliance on these forward-looking statements, which reflect management's current analysis of future events and should not be relied upon as representing management's expectations or beliefs as of any date subsequent to the time they are made. Genpact undertakes no obligation to update any forward-looking statements that may be made from time to time by or on behalf of Genpact.

Contacts

 

Investors

  

Roger Sachs, CFA

 

  

+1 (203) 808-6725

 

  

roger.sachs@genpact.com

 

 

Media

  

Michael Schneider

+1 (217) 260-5041

michael.schneider@genpact.com

 

 

 


 

GENPACT LIMITED AND ITS SUBSIDIARIES

Consolidated Balance Sheets

(Unaudited)

(In thousands, except per share data and share count)

 

 

As of December 31,

 

 

As of March 31,

 

 

 

2019

 

 

2020

 

Assets

 

 

 

 

 

 

 

 

Current assets

 

 

 

 

 

 

 

 

Cash and cash equivalents

 

$

467,096

 

 

$

401,624

 

Accounts receivable, net of reserve for doubtful receivables of $29,969 and allowance for credit losses of $33,724 as of December 31, 2019 and March 31, 2020, respectively

 

 

914,255

 

 

 

910,955

 

Prepaid expenses and other current assets

 

 

170,325

 

 

 

166,358

 

Total current assets

 

$

1,551,676

 

 

$

1,478,937

 

Property, plant and equipment, net

 

 

254,035

 

 

 

245,800

 

Operating lease right-of-use assets

 

 

330,854

 

 

 

342,377

 

Deferred tax assets

 

 

89,715

 

 

 

102,078

 

Intangible assets, net

 

 

230,861

 

 

 

215,036

 

Goodwill

 

 

1,574,466

 

 

 

1,554,679

 

Contract cost assets

 

 

205,498

 

 

 

211,066

 

Other assets, net of reserve for doubtful assets of $0 and allowance for credit losses of $2,153 as of December 31, 2019 and March 31, 2020, respectively

 

217,079

 

 

 

252,807

 

Total assets

 

$

4,454,184

 

 

$

4,402,780

 

 

 

 

 

 

 

 

 

 

Liabilities and equity

 

 

 

 

 

 

 

 

Current liabilities

 

 

 

 

 

 

 

 

Short-term borrowings

 

$

70,000

 

 

$

165,000

 

Current portion of long-term debt

 

 

33,509

 

 

 

33,517

 

Accounts payable

 

 

21,981

 

 

 

26,070

 

Income taxes payable

 

 

43,186

 

 

 

47,225

 

Accrued expenses and other current liabilities

 

 

683,871

 

 

 

611,145

 

Operating leases liability

 

 

57,664

 

 

 

61,100

 

Total current liabilities

 

$

910,211

 

 

$

944,057

 

Long-term debt, less current portion

 

 

1,339,796

 

 

 

1,331,689

 

Operating leases liability

 

 

302,100

 

 

 

310,829

 

Deferred tax liabilities

 

 

3,990

 

 

 

3,333

 

Other liabilities

 

 

208,916

 

 

 

239,793

 

Total liabilities

 

$

2,765,013

 

 

$

2,829,701

 

Shareholders’ equity

 

 

 

 

 

 

 

 

Preferred shares, $0.01 par value, 250,000,000 authorized, none issued

 

 

 

 

Common shares, $0.01 par value, 500,000,000 authorized,

190,118,181 and 190,201,079 issued and outstanding as of December 31, 2019 and March 31, 2020, respectively

 

 

1,896

 

 

 

1,898

 

Additional paid-in capital

 

 

1,570,575

 

 

 

1,566,191

 

Retained earnings

 

 

648,656

 

 

 

666,816

 

Accumulated other comprehensive income (loss)

 

 

(531,956

)

 

 

(661,826)

 

Total equity

 

$

1,689,171

 

 

$

1,573,079

 

Total liabilities and equity

 

$

4,454,184

 

 

$

4,402,780

 

 

 


 

GENPACT LIMITED AND ITS SUBSIDIARIES

Consolidated Statements of Income

(Unaudited)

(In thousands, except per share data and share count)

 

 

 

Three months ended March 31,

 

 

 

2019

 

 

2020

 

Net revenues

 

$

809,206

 

 

$

923,192

 

Cost of revenue

 

 

519,137

 

 

 

604,771

 

Gross profit

 

$

290,069

 

 

$

318,421

 

Operating expenses:

 

 

 

 

 

 

 

 

Selling, general and administrative expenses

 

 

191,402

 

 

 

197,342

 

Amortization of acquired intangible assets

 

 

8,509

 

 

 

10,741

 

Other operating (income) expense, net

 

 

86

 

 

 

(320

)

Income from operations

 

$

90,072

 

 

$

110,658

 

Foreign exchange gains (losses), net

 

 

(3,432

)

 

 

14,531

 

Interest income (expense), net

 

 

(11,123

)

 

 

(11,696

)

Other income (expense), net

 

 

3,803

 

 

 

(2,934

)

Income before equity-method investment activity, net and income tax expense

 

$

79,320

 

 

$

110,559

 

Equity-method investment activity, net

 

 

4

 

 

 

 

Income before income tax expense

 

$

79,324

 

 

$

110,559

 

Income tax expense

 

 

18,483

 

 

 

24,861

 

Net income attributable to Genpact Limited shareholders

 

$

60,841

 

 

$

85,698

 

Net income available to Genpact Limited common shareholders

 

$

60,841

 

 

$

85,698

 

Earnings per common share attributable to Genpact Limited common shareholders

 

 

 

 

 

 

 

 

Basic

 

$

0.32

 

 

$

0.45

 

Diluted

 

$

0.31

 

 

$

0.44

 

Weighted average number of common shares used in computing earnings per common share attributable to Genpact Limited common shareholders

 

 

 

 

 

 

 

 

Basic

 

 

189,451,845

 

 

 

190,626,757

 

Diluted

 

 

193,394,208

 

 

 

196,532,513

 

 

 


 

GENPACT LIMITED AND ITS SUBSIDIARIES

Consolidated Statements of Cash Flows

(Unaudited)

(In thousands)

 

 

 

Three months ended March 31,

 

 

 

2019

 

 

2020

 

Operating activities

 

 

 

 

 

 

 

 

Net income attributable to Genpact Limited shareholders

 

$

60,841

 

 

$

85,698

 

Adjustments to reconcile net income to net cash used for operating activities:

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

21,919

 

 

 

28,494

 

Amortization of debt issuance costs (including loss on extinguishment of debt)

 

 

443

 

 

 

561

 

Amortization of acquired intangible assets

 

 

8,509

 

 

 

10,741

 

Reserve for doubtful receivables/allowance for credit losses

 

 

2,026

 

 

 

2,156

 

Unrealized loss (gain) on revaluation of foreign currency asset/liability

 

 

257

 

 

 

(9,655

)

Stock-based compensation expense

 

 

18,461

 

 

 

17,487

 

Deferred tax expense (benefit)

 

 

(5,522

)

 

 

(392

)

Others, net

 

 

(508

)

 

 

(348

)

Change in operating assets and liabilities:

 

 

 

 

 

 

 

 

Increase in accounts receivable

 

 

(64,763

)

 

 

(3,858

)

Increase in prepaid expenses, other current assets, contract cost assets, operating lease right-of-use assets and other assets

 

 

(36,220

)

 

 

(84,098

)

Increase (decrease) in accounts payable

 

 

(12,189

)

 

 

4,557

 

Decrease in accrued expenses, other current liabilities, operating leases liability and other liabilities

 

 

(12,087

)

 

 

(74,788

)

Increase in income taxes payable

 

 

13,417

 

 

 

4,796

 

Net cash used for operating activities

 

$

(5,416

)

 

$

(18,649

)

 

 

 

 

 

 

 

 

 

Investing activities

 

 

 

 

 

 

 

 

Purchase of property, plant and equipment

 

 

(14,072

)

 

 

(20,956

)

Payment for internally generated intangible assets (including intangibles under development)

 

 

(7,914

)

 

 

(3,236

)

Proceeds from sale of property, plant and equipment

 

 

1,478

 

 

 

312

 

Payment for business acquisitions, net of cash acquired

 

 

(6,305

)

 

 

 

Net cash used for investing activities

 

$

(26,813

)

 

$

(23,880

)

Financing activities

 

 

 

 

 

 

 

 

Repayment of finance lease obligations

 

 

(1,780

)

 

 

(1,950

)

Payment of debt issuance costs

 

 

 

 

 

(620

)

Repayment of long-term debt

 

 

(8,500

)

 

 

(8,500

)

Proceeds from short-term borrowings

 

 

50,000

 

 

 

125,000

 

Repayment of short-term borrowings

 

 

(25,000

)

 

 

(30,000

)

Proceeds from issuance of common shares under stock-based compensation plans

 

 

4,599

 

 

 

4,063

 

Payment for net settlement of stock-based awards

 

 

(652

)

 

 

(26,238

)

Payment of earn-out consideration

 

 

(8,400

)

 

 

 

Dividend paid

 

 

(16,119

)

 

 

(18,543

)

Payment for stock repurchased and retired

 

 

 

 

 

(45,000

)

Payment for expenses related to stock repurchase

 

 

 

 

 

(21

)

Net cash used for financing activities

 

$

(5,852

)

 

$

(1,809

)

Effect of exchange rate changes

 

 

(4,938

)

 

 

(21,134

)

Net decrease in cash and cash equivalents

 

 

(38,081

)

 

 

(44,338

)

Cash and cash equivalents at the beginning of the period

 

 

368,396

 

 

 

467,096

 

Cash and cash equivalents at the end of the period

 

$

325,377

 

 

$

401,624

 

Supplementary information

 

 

 

 

 

 

 

 

Cash paid during the period for interest

 

$

8,486

 

 

$

5,295

 

Cash paid during the period for income taxes, net of refund

 

$

19,286

 

 

$

69,357

 

Right-of-use assets acquired under finance lease obligations

 

$

1,433

 

 

$

10,353

 

 

 


 

Non-GAAP Financial Measures

To supplement the consolidated financial statements presented in accordance with GAAP, this press release includes the following non-GAAP financial measures:

 

Adjusted income from operations attributable to shareholders of Genpact Limited, or adjusted income from operations;

 

Adjusted income from operations margin;

 

Adjusted diluted earnings per share attributable to shareholders of Genpact Limited, or adjusted diluted earnings per share; and

 

Revenue growth on a constant currency basis.

These non-GAAP financial measures are not based on any comprehensive set of accounting rules or principles and should not be considered a substitute for, or superior to, financial measures calculated in accordance with GAAP, and may be different from non-GAAP financial measures used by other companies. Accordingly, these non-GAAP financial measures, the financial statements prepared in accordance with GAAP and the reconciliations of Genpact’s GAAP financial statements to such non-GAAP financial measures should be carefully evaluated.

Prior to July 2012, Genpact’s management used financial statements that excluded significant acquisition-related expenses, amortization of related acquired intangibles, and amortization of acquired intangibles recorded at the company’s formation in 2004 for its internal management reporting, budgeting and decision-making purposes, including comparing Genpact’s operating results to that of its competitors. However, considering Genpact’s frequent acquisitions of varying scale and size, and the difficulty in predicting expenses relating to acquisitions and the amortization of acquired intangibles thereof, since July 2012 Genpact’s management has used financial statements that exclude all acquisition-related expenses and amortization of acquired intangibles for its internal management reporting, budgeting and decision-making purposes, including comparing Genpact’s operating results to those of its competitors. For the same reasons, since April 2016 Genpact’s management has excluded the impairment of acquired intangible assets from the financial statements it uses for internal management purposes. Acquisition-related expenses are excluded in the period in which an acquisition is consummated.

Genpact’s management also uses financial statements that exclude stock-based compensation expense. Because of varying available valuation methodologies, subjective assumptions and the variety of award types that companies can use when adopting ASC 718 “Compensation-Stock Compensation,” Genpact’s management believes that providing non-GAAP financial measures that exclude such expenses allows investors to make additional comparisons between Genpact’s operating results and those of other companies. Additionally, in its calculations of such non-GAAP financial measures, Genpact’s management has adjusted foreign exchange gains and losses, interest income and expense and income tax expenses from GAAP net income attributable to Genpact Limited shareholders, and other income and expenses, certain gains, losses and impairment charges attributable to equity-method investments, and gains or losses attributable to non-controlling interests from GAAP income from operations and GAAP earnings per share, because management believes that the Company’s results after taking into account these adjustments more accurately reflect the Company’s ongoing operations. For the purpose of calculating adjusted diluted earnings per share, the combined current and deferred tax effect is determined by multiplying each pre-tax adjustment by the applicable statutory income tax rate.

Genpact’s management provides information about revenues on a constant currency basis so that the revenues may be viewed without the impact of foreign currency exchange rate fluctuations as compared to the prior fiscal periods, thereby facilitating period-to-period comparisons of the Company’s true business performance. Revenue growth on a constant currency basis is calculated by restating current-period activity using the prior fiscal period’s foreign currency exchange rates adjusted for hedging gains/losses in such period.

Accordingly, Genpact believes that the presentation of adjusted income from operations, adjusted income from operations margin, adjusted diluted earnings per share and revenue growth on a constant currency basis, when read in conjunction with the Company’s reported results, can provide useful supplemental information to investors and management regarding financial and business trends relating to its financial condition and results of operations.

A limitation of using adjusted income from operations and adjusted income from operations margin versus income from operations, income from operations margin, net income attributable to Genpact Limited shareholders and net income attributable to Genpact Limited shareholders margin calculated in accordance with GAAP is that these non-GAAP financial measures exclude certain recurring costs and certain other charges, namely stock-based compensation and amortization and impairment of acquired intangibles. Management compensates for this limitation by providing specific information on the GAAP amounts excluded from adjusted income from operations and adjusted income from operations margin.

 


 

 

The following tables show the reconciliation of these non-GAAP financial measures to the most directly comparable GAAP measures for the three months ended March 31, 2019 and 2020:

Reconciliation of Net income attributable to Genpact Limited shareholders/Margin to Adjusted Income from Operations/Margin

(Unaudited)

(In thousands)

 

 

 

Three months ended March 31,

 

 

 

2019

 

 

2020

 

Net income attributable to Genpact Limited shareholders

 

$

60,841

 

 

$

85,698

 

Foreign exchange (gains) losses, net

 

 

3,432

 

 

 

(14,531

)

Interest (income) expense, net

 

 

11,123

 

 

 

11,696

 

Income tax expense

 

 

18,483

 

 

 

24,861

 

Stock-based compensation expense

 

 

18,461

 

 

 

17,487

 

Amortization of acquired intangible assets

 

 

8,204

 

 

 

10,514

 

Acquisition-related expenses

 

 

967

 

 

-

 

Adjusted income from operations

 

$

121,511

 

 

$

135,725

 

Net income attributable to Genpact Limited shareholders margin

 

 

7.5

%

 

 

9.3

%

Adjusted income from operations margin

 

 

15.0

%

 

 

14.7

%

Reconciliation of Income from Operations/Margin to Adjusted Income from Operations/Margin

(Unaudited)

(In thousands)

 

 

 

Three months ended March 31,

 

 

 

2019

 

 

2020

 

Income from operations

 

$

90,072

 

 

$

110,658

 

Stock-based compensation expense

 

 

18,461

 

 

 

17,487

 

Amortization of acquired intangible assets

 

 

8,204

 

 

 

10,514

 

Acquisition-related expenses

 

 

967

 

 

-

 

Other income (expense), net

 

 

3,803

 

 

 

(2,934

)

Equity-method investment activity, net

 

 

4

 

 

-

 

Adjusted income from operations

 

$

121,511

 

 

$

135,725

 

Income from operations margin

 

 

11.1

%

 

 

12.0

%

Adjusted income from operations margin

 

 

15.0

%

 

 

14.7

%

 

 


Reconciliation of Diluted EPS to Adjusted Diluted EPS4

(Unaudited)

(Per share data) 

 

 

 

Three months ended March 31,

 

 

 

2019

 

 

2020

 

Diluted EPS

 

$

0.31

 

 

$

0.44

 

Stock-based compensation expense

 

 

0.10

 

 

 

0.09

 

Amortization of acquired intangible assets

 

 

0.04

 

 

 

0.05

 

Acquisition-related expenses

 

 

0.00

 

 

-

 

Tax impact on stock-based compensation

 

 

(0.02

)

 

 

(0.04

)

Tax impact on amortization of acquired intangible assets

 

 

(0.01

)

 

 

(0.01

)

Tax impact on acquisition-related expenses

 

 

(0.00

)

 

-

 

Adjusted diluted EPS

 

$

0.43

 

 

$

0.53

 

 

 

4 

Due to rounding, the numbers presented in this table may not add up precisely to the totals provided.